Target intelligence / Profile preview

Infant gut microbiome composition and function

Molecular classification
Other (Microbial community), Other (Biological system)
01

Overview

The infant gut microbiome refers to the complex community of microorganisms, including bacteria, viruses, and fungi, that colonize the gastrointestinal tract during the first years of life (Milani et al., 2017). This ecosystem is fundamental to human health, serving as a primary driver for the maturation of the mucosal immune system and the establishment of metabolic homeostasis (Arrieta et al., 2014). The composition is highly sensitive to early-life exposures such as delivery mode, breastfeeding, and antibiotic use, with a critical window of development that influences long-term health outcomes (Bokulich et al., 2016). Dysbiosis in this system is strongly associated with the pathogenesis of necrotizing enterocolitis in preterm infants and the later development of allergic and autoimmune diseases (Warner et al., 2016). Therapeutic strategies, including the use of live biotherapeutic products (LBPs) and prebiotics, aim to restore or maintain a healthy microbial assembly to prevent or treat these conditions (Underwood et al., 2015).

Other names
Infant gut microbiotaNeonatal intestinal microbiomeEarly-life gut microbiomeInfant intestinal flora
02

Mechanism of action

Modulation of the microbial ecosystem through the introduction of beneficial commensal strains (probiotics), provision of selective substrates (prebiotics), or elimination of pathogenic taxa (antibiotics) to restore homeostatic balance and support host physiological development (Hill et al., 2014).

03

Biological functions

Immune responseOther (Nutrient metabolism)Other (Pathogen exclusion)Other (Gut barrier maintenance)Other (Vitamin synthesis)
04

Disease associations

InflammationInfectionOther (Necrotizing enterocolitis)Other (Asthma)Other (Atopic dermatitis)Other (Obesity)
05

Safety considerations

Risk of bacteremia or sepsis in preterm or immunocompromised infantsHorizontal gene transfer of antibiotic resistance genesPotential for long-term immune dysregulationVariable colonization efficacy and strain-specific effects
06

Interacting drugs

Bifidobacterium longum subsp. infantis (EVC001)

4 more in the full profile.

07

Biomarkers

Alpha diversity (Shannon index)Bifidobacterium abundanceFecal short-chain fatty acid levelsFecal calprotectinProteobacteria-to-Actinobacteria ratio

Beyond the preview

Go deeper on Infant gut microbiome composition and function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infant gut microbiome composition and function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call